Table 3 The relationship between αIE antibodies before CHMI, expression of specific var subclasses after CHMI and PMR (outcome measure). uncorrected p-values are shown
Models | Explanatory variables | Coeff(95% CI) | p-value | Adjusted R2 |
|---|---|---|---|---|
1 | gpA1 | 1.18(0.06, 2.30) | 0.04 | 13% |
2 | gpA3 | 1.55(0.06,3.05) | 0.04 | 12% |
3 | dc8-1 | 1.73(0.62,2.85) | 0.004 | 26% |
4 | gpA_median | 0.33(0.03, 0.63) | 0.03 | 14% |
5 | Dc8_median | 1.32(0.07,2.58) | 0.04 | 12% |
6 | gpA_prop | 7.88(2.73,13.02) | 0.004 | 26% |
7 | dc8_prop | 7.85(−0.09,15.79) | 0.05 | 11% |
8 | c1_prop | −9.26(−14.85, −3.66) | 0.003 | 29% |
9 | gpA_prop2 | 7.25(2.77,11.73) | 0.003 | 28% |
10 | c1_prop2 | −8.93(−14.50, −3.37) | 0.003 | 28% |
11 | αIE | 1.99(0.42, 3.55) | 0.02 | 18% |
12 | gpA1 | 0.42(−1.12,1.97) | 0.6 | 16% |
αIE | 1.55(−0.69,3.80) | 0.17 |  | |
13 | gpA3 | 0.91(−0.69,2.52) | 0.3 | 20% |
αIE | 1.54(−0.21,3.28) | 0.08 |  | |
14 | dc8-1 | 1.32(0.06,2.58) | 0.04 | 29% |
αIE | 1.12(−0.56,2.80) | 0.2 |  | |
15 | gpA_median | 0.18 (−0.18, 0.53) | 0.3 | 19% |
αIE | 1.44 (−0.46, 3.35) | 0.1 |  | |
16 | dc8_median | 0.66(−0.81, 2.14) | 0.4 | 18% |
αIE | 1.50 (−0.40, 3.41) | 0.1 |  | |
17 | gpA_prop | 6.0 (−1.08, 13.10) | 0.1 | 25% |
αIE | 0.80 (−1.26, 2.85) | 0.4 |  | |
18 | dc8_prop | 4.65(−3.67, 12.96) | 0.3 | 19% |
αIE | 1.59 (−0.12, 3.31) | 0.07 |  | |
19 | c1_prop | −7.31 (−13.45, −1.17) | 0.02 | 32% |
αIE | 1.13 (−0.47, 2.73) | 0.2 |  | |
20 | gpA_prop2 | 5.80(−0.32,11.92) | 0.06 | 26% |
αIE | 0.71(−1.30,2.72) | 0.5 |  | |
21 | c1_prop2 | −7.0(−13.03, −0.95) | 0.03 | 31% |
αIE | 1.18(−0.43,2.78) | 0.1 |  |